This Government Contract opportunity from Department Of Health And Human Services was posted on April 29, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Intent to Sole Source - Preventative Maintenance Agreement for 4 Apheresis Machines (Optias)
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The National Institutes of Health, Clinical Center, intends to award a sole-source service agreement to Terumo BCT for the preventive maintenance and emergency repair of four Spectra OPTIA apheresis machines used in patient care and donor procedures at its Blood Services Section in Bethesda, Maryland. This procurement is justified under FAR 6.302-1, as Terumo BCT is the only responsible source capable of servicing these proprietary devices due to their specialized design, proprietary software, and the critical need to comply with FDA and AABB regulatory standards for patient safety. The service agreement has a base period of one year, from June 2, 2026, through June 2, 2027, with two optional one-year extensions, for a potential total contract duration of three years. The estimated value of the base period is $84,836.56, which covers biannual preventive maintenance, 24/7 telephone support, emergency on-site response within one business day, all necessary labor and travel, replacement parts, and compliance with Terumo’s official service manuals. Unauthorized maintenance or use of non-OEM parts would violate regulatory requirements and jeopardize the integrity of clinical procedures, making competition infeasible. A notice of intent has been issued, and responsible sources may submit a capability statement by email to valerie.gregorio@nih.gov with the subject line referencing NOI-OLAO-CC-26-005158 by 12:00 PM Eastern Standard Time on May 13, 2026, though any such submissions will not alter the government’s intent to proceed with a sole-source award. The contract is classified under NAICS code 339112 and does not involve any set-aside provisions or socioeconomic preferences. Performance will occur exclusively at the NIH Clinical Center, and all services must adhere strictly to manufacturer guidelines and federal health regulations to ensure uninterrupted operation of life-critical apheresis systems used in transplant, therapeutic apheresis, and research protocols.
General Info
Agency
NAICS
Place of Performance
Bethesda, MD, 20892, USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
This is a Notice of Intent, not a request for proposal. The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with the following vendor: Terumo BCT.
Acquisition Descripton:
The National Institutes of Health, Office of Purchasing and Contracts on behalf of Clinical Center (CC), Blood Services Section (BSS) has a need to approve a "Justification for Other Than Full and Open" requirement in accordance with FAR 8.3, Other Than Full and Open Competition.
This procurement action in accordance with IAW FAR 6.302-1 is based on the need to procure a service agreement for our apheresis machines which are used in a patient care capacity. Service Agreement is for a one-year period with the two option years.
Approval of this purchase is for service agreement for a specific type of instrument which is used to separate blood and blood products on donors and patients in the NIH Clinical Center.
The DTM is a unique blood center which collects blood and blood components from healthy donors for patients participating in many protocols. However, blood and blood products are also withdrawn from patients when prescribed by a physician, which may have a therapeutic benefit to treat their medical condition. These two (2) apheresis machines are used to perform extracorporeal therapy in which the blood of donors or patients is passed through the device to separate blood components. Numerous regulatory authorities, specifically the Food and Drug Administration (FDA) and AABB set policy and enforce this policy for care and maintenance of equipment that is used, in support of donors and patients per the above.
The statutory authority for this sole source requirement is 41 U.S.C. 253(c) (1) as implemented by FAR 6.302-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide the required may submit a capability statement that will be considered by email (subject line to reference NOI-OLAO-CC-26-005158) by 12:00 PM eastern standard time on 05/13/2026 to: valerie.gregorio@nih.gov.
All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.
More opportunities from Department Of Health And Human Services → National Institutes Of Health
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
